BioSig Stock (NASDAQ:BSGM)


RevenueOwnershipFinancialsChart

Previous Close

$1.98

52W Range

$0.20 - $5.00

50D Avg

$0.67

200D Avg

$0.82

Market Cap

$28.49M

Avg Vol (3M)

$199.03K

Beta

0.35

Div Yield

-

BSGM Company Profile


BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Oct 31, 2014

Website

BSGM Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Service$18.00K$32.00K$27.00K
Product-$254.00K$414.00K

Fiscal year ends in Dec 23 | Currency in USD

BSGM Financial Summary


Dec 23Dec 22Dec 21
Revenue$18.00K$286.00K$441.00K
Operating Income$-28.51M$-27.27M$-33.41M
Net Income$-29.04M$-27.27M$-31.36M
EBITDA$-28.15M$-26.97M$-33.77M
Basic EPS$-3.95$-6.40$-9.36
Diluted EPS$-3.95$-6.40$-9.36

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
BMRABiomerica, Inc.
APYXApyx Medical Corporation
CTSOCytosorbents Corporation
TIVCTivic Health Systems, Inc.
LUNGPulmonx Corporation
CLPTClearPoint Neuro, Inc.
NUWENuwellis, Inc.
NPCENeuroPace, Inc.
TELATELA Bio, Inc.
SRDXSurmodics, Inc.
NMTCNeuroOne Medical Technologies Corporation
KIDSOrthoPediatrics Corp.
XAIRBeyond Air, Inc.
BBLGBone Biologics Corporation
BJDXBluejay Diagnostics, Inc.
HSCSHeart Test Laboratories, Inc.
INGNInogen, Inc.
VVOSVivos Therapeutics, Inc.
NAOVNanoVibronix, Inc.